Apolipoprotein E ε4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease

被引:515
作者
Kivipelto, M
Helkala, EL
Laakso, MP
Hänninen, T
Hallikainen, M
Alhainen, K
Iivonen, S
Mannermaa, A
Tuomilehto, J
Nissinen, A
Soininen, H
机构
[1] Univ Kuopio, Dept Neurol & Neurosci, FIN-70211 Kuopio, Finland
[2] Kuopio Univ Hosp, SF-70210 Kuopio, Finland
[3] N Karelia Cent Hosp, Joensuu, Finland
[4] Natl Publ Hlth Inst, Helsinki, Finland
关键词
D O I
10.7326/0003-4819-137-3-200208060-00006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Presence of the apolipoprotein E (apoE) epsilon4 allele, which is involved in cholesterol metabolism, is the most important genetic risk factor for Alzheimer disease. Elevated midlife values for total cholesterol level and blood pressure have been implicated recently as risk factors for Alzheimer disease. Objective: To study the relative importance and the putative relationship among the apoE epsilon4 allele, midlife total cholesterol level, and midlife blood pressure as risk factors for late-life Alzheimer disease. Design: Prospective population-based study. Setting: Kuopio and Joensuu, eastern Finland. Participants: Participants were derived from random population surveys from 1972, 1977, 1982, and 1987. A total of 1449 persons (73%), 65 to 79 years of age, participated in the reexamination in 1998 (mean follow-up, 21 years). Measurements: Midlife blood pressure and total cholesterol level, apoE genotype, and development of Alzheimer disease during follow-up. Results: The apoE epsilon4 allele was an independent risk factor for Alzheimer disease, even after adjustment for midlife vascular risk factors and other confounders (odds ratio, 2.1 [95% Cl, 1.1 to 4.1]). Similarly, elevated midlife values for serum total cholesterol level (odds ratio, 2.8 [Cl, 1.2 to 6.7]) and systolic blood pressure (odds ratio, 2.6 [Cl, 1.1 to 6.6]) were independent risk factors for Alzheimer disease, even after adjustment for apoE genotype and other confounding factors. Conclusions: The association between the apoE epsilon4 allele and Alzheimer disease does not seem to be mediated by vascular factors. The apoE epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for Alzheimer disease. The risk for Alzheimer disease from treatable factors-elevated total cholesterol level and blood pressure appears to be greater than that from the apoE epsilon4 allele.
引用
收藏
页码:149 / 155
页数:7
相关论文
共 30 条
[1]   APOE GENOTYPE AND SURVIVAL FROM INTRACEREBRAL HEMORRHAGE [J].
ALBERTS, MJ ;
GRAFFAGNINO, C ;
MCCLENNY, C ;
DELONG, D ;
STRITTMATTER, W ;
SAUNDERS, AM ;
ROSES, AD .
LANCET, 1995, 346 (8974) :575-575
[2]  
Braak E, 1999, EUR ARCH PSY CLIN N, V249, P14
[3]   Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset [J].
Brookmeyer, R ;
Gray, S ;
Kawas, C .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1998, 88 (09) :1337-1342
[4]   Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins [J].
Carmelli, D ;
Swan, GE ;
Reed, T ;
Miller, B ;
Wolf, PA ;
Jarvik, GP ;
Schellenberg, GD .
NEUROLOGY, 1998, 50 (06) :1580-1585
[5]  
Coca A, 1998, J HYPERTENS, V16, pS45
[6]   APOE genotype predicts AD and other dementia but not ischemic cerebrovascular disease [J].
Frikke-Schmidt, R ;
Nordestgaard, BG ;
Thudium, D ;
Gronholdt, MLM ;
Tybjærg-Hansen, A .
NEUROLOGY, 2001, 56 (02) :194-200
[7]   The role of APOE ε4 in modulating effects of other risk factors for cognitive decline in elderly persons [J].
Haan, MN ;
Shemanski, L ;
Jagust, WJ ;
Manolio, TA ;
Kuller, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (01) :40-46
[8]   Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study [J].
Hofman, A ;
Ott, A ;
Breteler, MMB ;
Bots, ML ;
Slooter, AJC ;
vanHarskamp, F ;
vanDuijn, CN ;
Van Broeckhoven, C ;
Grobbee, DE .
LANCET, 1997, 349 (9046) :151-154
[9]   INTERACTIONS OF APOLIPOPROTEIN-E GENOTYPE, TOTAL CHOLESTEROL LEVEL, AGE, AND SEX IN PREDICTION OF ALZHEIMERS-DISEASE - A CASE-CONTROL STUDY [J].
JARVIK, GP ;
WIJSMAN, EM ;
KUKULL, WA ;
SCHELLENBERG, GD ;
YU, C ;
LARSON, EB .
NEUROLOGY, 1995, 45 (06) :1092-1096
[10]   Statins and the risk of dementia [J].
Jick, H ;
Zornberg, GL ;
Jick, SS ;
Seshadri, S ;
Drachman, DA .
LANCET, 2000, 356 (9242) :1627-1631